Digital therapeutics, or DTx, is a hot topic in the scientific world, drawing attention from all over. This review dives into what DTx is and how it can help treat various diseases, comparing it to traditional drug treatments. It also looks at the good and bad parts of the current European laws on DTx. DTx is like a new tool in the healthcare toolbox. It uses digita...

Ever wondered how scientists might one day fix genetic diseases? R2 retrotransposons could be the key. These tiny genetic elements can slip new genes into specific spots in our cells. Here's how scientists can check if R2 retrotransposons are doing their job right in mammalian cells. First, they make special vectors. These vectors carry the recipe for R2 proteins an...

Outlook Therapeutics, known by its ticker OTLK, has recently highlighted a new set of challenges. The company relies heavily on external manufacturers, primarily FUJIFILM Diosynth Biotechnologies, for making and supplying their drug candidates like ONS-5010/LYTENAVA. This outsourcing isn't without its drawbacks. Potential delays in clinical trials and product launch ...

Scientists are working on a new way to see and treat cancer. They are targeting proteins called BRD3 and BRD4, which are found in many types of cancer cells. Right now, doctors mainly use antibodies to spot these proteins. But these antibodies can be pricey and hard to use. Plus, they can't help treat the cancer. So, scientists created some special molecules called f...

Eating disorders (EDs) are a serious health issue, and finding ways to help more people is a big goal for public health. One idea is to use apps to provide support and treatment. Some apps offer real-time help and messages, but do they really make a difference? And can they help people use health services better? Not much is known about this yet. A study looked at h...